FDA Eyes Alpharma's Embeda Over Abuse Effects
By Erin Marie Daly · November 12, 2008, 12:00 AM EST
U.S. Food and Drug Administration officials are concerned that design features meant to cut down on abuse of Alpharma Inc.'s Embeda aren't enough to prevent addicts from misusing the potent painkiller....
To view the full article, register now.